Dr. Dabaja focuses his research on Chimeric Antigen Receptor T-cell Therapy (CAR T), haploidentical transplantation, reduced intensity conditioning regimens for lymphoid malignancies, vaccine therapy for CMV in the setting of allogeneic HCT, graft versus host disease (acute and chronic), personalized cancer care using genomics in hematopoietic cell transplantation, and evidence-based medicine in hematopoietic cell transplantation.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Jazz Pharmaceuticals
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube


Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect


Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811